Cargando…
Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk
BACKGROUND: Taiwan has the highest renal disease incidence and prevalence in the world. We evaluated the association of statin and renin–angiotensin system inhibitor (RASI) use with dialysis risk in hypertensive patients. METHODS: Of 248,797 patients who received a hypertension diagnosis in Taiwan d...
Autores principales: | Liu, Ju-Chi, Hsu, Yi-Ping, Wu, Szu-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025231/ https://www.ncbi.nlm.nih.gov/pubmed/27632175 http://dx.doi.org/10.1371/journal.pone.0162588 |
Ejemplares similares
-
Effects of Statins on Renin–Angiotensin System
por: Kiaie, Nasim, et al.
Publicado: (2021) -
Brain renin–angiotensin system: Is it important in dialysis patients?
por: Demir, Murat, et al.
Publicado: (2009) -
Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension
por: Azegami, Tatsuhiko, et al.
Publicado: (2019) -
GENETIC INFLUENCE ON THE RENIN-ANGIOTENSIN SYSTEM : EVIDENCE FOR A RENIN INHIBITOR IN HYPERTENSION-PRONE RATS
por: Iwai, Junichi, et al.
Publicado: (1970) -
Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)